Funding

BacAlt Biosciences raises Rs 18 crore in round led by Avaana Capital

Published

on

[ad_1]

Biotech startup BacAlt Biosciences has raised Rs 18 crore in a funding round led by early-stage investment firm Avaana Capital.

The round also saw participation from Lubrizol InnoVentures, the innovation arm of global speciality chemicals provider Lubrizol.

The startup will use the funds to scale R&D processes, build pilot production facilities, expand its team, and develop go-to-market strategies for geographic expansion.

“Just getting rid of packaging or making your packaging recyclable or biodegradable is not good enough. We have to think about…

[ad_2]

Source link

Exit mobile version